ENBIO Statistics

Total Valuation

ENBIO has a market cap or net worth of KRW 25.76 billion. The enterprise value is 39.30 billion.

Market Cap	25.76B
Enterprise Value	39.30B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ENBIO has 10.87 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	10.87M
Shares Outstanding	10.87M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	30.61%
Owned by Institutions (%)	n/a
Float	7.54M

Valuation Ratios

The trailing PE ratio is 181.77.

PE Ratio	181.77
Forward PE	n/a
PS Ratio	0.77
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	52.34
P/OCF Ratio	6.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.80, with an EV/FCF ratio of 79.85.

EV / Earnings	277.51
EV / Sales	1.17
EV / EBITDA	20.80
EV / EBIT	160.73
EV / FCF	79.85

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.37.

Current Ratio	2.06
Quick Ratio	0.14
Debt / Equity	0.37
Debt / EBITDA	8.69
Debt / FCF	33.37
Interest Coverage	0.38

Financial Efficiency

Return on equity (ROE) is 0.32% and return on invested capital (ROIC) is 0.25%.

Return on Equity (ROE)	0.32%
Return on Assets (ROA)	0.21%
Return on Invested Capital (ROIC)	0.25%
Return on Capital Employed (ROCE)	0.50%
Revenue Per Employee	419.52M
Profits Per Employee	1.77M
Employee Count	80
Asset Turnover	0.47
Inventory Turnover	1.40

Taxes

In the past 12 months, ENBIO has paid 136.49 million in taxes.

Income Tax	136.49M
Effective Tax Rate	49.08%

Stock Price Statistics

The stock price has decreased by -1.63% in the last 52 weeks. The beta is 0.95, so ENBIO's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-1.63%
50-Day Moving Average	2,551.80
200-Day Moving Average	2,335.00
Relative Strength Index (RSI)	38.44
Average Volume (20 Days)	12,648

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ENBIO had revenue of KRW 33.56 billion and earned 141.61 million in profits. Earnings per share was 13.04.

Revenue	33.56B
Gross Profit	10.44B
Operating Income	244.50M
Pretax Income	278.10M
Net Income	141.61M
EBITDA	1.89B
EBIT	244.50M
Earnings Per Share (EPS)	13.04

Full Income Statement

Balance Sheet

The company has 2.88 billion in cash and 16.42 billion in debt, giving a net cash position of -13.54 billion or -1,246.04 per share.

Cash & Cash Equivalents	2.88B
Total Debt	16.42B
Net Cash	-13.54B
Net Cash Per Share	-1,246.04
Equity (Book Value)	43.97B
Book Value Per Share	4,104.97
Working Capital	21.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.94 billion and capital expenditures -3.45 billion, giving a free cash flow of 492.13 million.

Operating Cash Flow	3.94B
Capital Expenditures	-3.45B
Free Cash Flow	492.13M
FCF Per Share	45.28

Full Cash Flow Statement

Margins

Gross margin is 31.12%, with operating and profit margins of 0.73% and 0.42%.

Gross Margin	31.12%
Operating Margin	0.73%
Pretax Margin	0.83%
Profit Margin	0.42%
EBITDA Margin	5.63%
EBIT Margin	0.73%
FCF Margin	1.47%

Dividends & Yields

ENBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	n/a
Earnings Yield	0.55%
FCF Yield	1.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ENBIO has an Altman Z-Score of 1.28 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	7